Recent progress in cancer care continue to provide optimism for patients. Investigators are intensely exploring innovative approaches, including immune therapies , targeted agents, and individualized medicine . A significant finding published this week demonstrates the efficacy of a new drug in treating late-stage NSCLC. Furthermore, ongoing studie